Breast Cancer Exercise Intervention Study (BREXINT)
Early-stage Breast Cancer, Locally Advanced Breast Cancer
About this trial
This is an interventional treatment trial for Early-stage Breast Cancer focused on measuring BREXINT, Muscular Strength, Cardiorespiratory Fitness, Quality of Life
Eligibility Criteria
Inclusion Criteria: Patients with histologically or cytologically proven stage 1, 2, or 3 breast cancer Patients who have undergone curative breast surgery Patients who have received (neo)adjuvant chemotherapy (if given) and/or radiotherapy (if given) Females aged 21 years and older ≤ 8 weeks from breast surgery, or the last adjuvant chemotherapy or radiotherapy session, whichever is latest. Exclusion Criteria: Cardiovascular, respiratory, musculoskeletal problems that preclude moderate physical activity. Major medical problems that are deemed by the investigator to be unsuitable for enrollment.
Sites / Locations
- National University HospitalRecruiting
- National Cancer CentreRecruiting
- Singapore General HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Exercise
Control
The exercise intervention group will undergo an aerobic exercise and strength training programme, comprising 3 sessions per week, spanning 24 weeks (total: 3x24=72 sessions).
The usual care group.